Ep 297 - J&J MedTech’s Devi Govender wants to change the lives – and the language – of heart recovery patients

In this episode of the DeviceTalks Weekly Podcast, Managing Editor Kayleen Brown sits down with Johnson & Johnson MedTech Heart Recovery Worldwide President Devi Govender at DeviceTalks Boston.

Govender shares how a deeply personal family experience shaped her mission to transform cardiovascular care. She reflects on Abiomed's integration into Johnson & Johnson, the evolution of heart recovery therapies, and why the industry must shift its mindset from treating "heart failure" to enabling "heart recovery." The discussion explores patient-centered innovation, AI, clinical evidence, and the power of combining technologies, data, and advocacy to redefine the future of cardiovascular care for patients around the world.

This episode is sponsored by  Freudenberg Medical. Listen for a conversation with Shane Healy, Senior Director of Technology. Visit FreudenbergMedical.com for more information.

We'll kick off this episode with Newmarker's Newsmakers. Host Tom Salemi and MassDevice Editor Chris Newmarker revisit the top MedTech stories of the week: Zeta Surgical, Hologic, Medtronic, Fractyl Health, and Vicarious Surgical.

---

Enjoy the show? Follow DeviceTalks Weekly on all major podcast platforms, and subscribe to YouTube.com/@DeviceTalks so you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Subscribe today at [https://devicetalks.castos.com/subscribe](https://devicetalks.castos.com/subscribe).

Chapters

• (00:09:10) - Zeta wins FDA clearance for TMS robotic stereotactic system
• (00:13:01) - Private equity firms reportedly set $4B price on Hologic Surgical unit
• (00:15:03) - Medtronic, FDA pick up legal victories in spinal cord stimulator suits
• (00:16:20) - Fractyl Health says its single-catheter treatment maintained most GLP-1 weight loss
• (00:22:17) - Vicarious Surgical's board wants to shut down and liquidate the robotics developer